It’s a commonly known fact that the current global pandemic caused by the coronavirus originated in Wuhan, China. Over the first 50 days, a series of control measures were implemented to impede the spread, but were these measures effective?
There has been much contention regarding how the deadly COVID-19 pandemic originated. The first reported case of the disease was in Wuhan (Hubei province, China). The virus – SARS-CoV-2 – is believed to have been passed from animals to humans, but new data reveals pangolins could be linked to COVID-19 transmission.
Take a look behind the scenes of a recent Future Virology editorial entitled, ‘An insight into dengue virus proteins as potential drug/vaccine targets’, as we ask author Muhammad Faheem about recent advances in understanding dengue proteins and where the next 5–10 years could take us.
Catch up on February’s industry headlines, including an MRSA breakthrough, a patent lawsuit, and the latest updates on the coronavirus outbreak and its impact on the biotechnology industry worldwide.
A new study in The Lancet has suggested that the novel coronavirus was most genetically similar to two SARS-like coronaviruses of bat origin, but that there may be the possibility of another animal host acting as an intermediate host between bats and humans.
Take a look at the industry headlines from the last 2 months, including the FDA approval of Ebola vaccine Ervebo,…
Scientists have synthetically engineered mosquitoes to prevent transmission of dengue virus to humans. This potentially could lead to genetic approaches to controlling the spread of dengue virus among populations.
As we head into 2020, we review the biggest outbreaks of 2019 and the impact they had – from growing cases of measles across the globe to the outbreaks as a result of ongoing instability in Yemen – take a look to find out more.
Take a look at this month’s industry headlines including results for Takeda’s dengue vaccine, approvals for Merck’s Ebola vaccine and the advent of a siderophore antibiotic – the first of this kind.
A team of researchers presented the first large-scale evidence that releasing Wolbachia-infected mosquitoes reduced dengue infections by >70% in high-risk populations.
